Navigation Links
Integrity Applications, Inc. Announces Equity Financing of $3.0 Million
Date:9/3/2014

ASHKELON, Israel, Sept. 3, 2014 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP) ("Integrity"), announced today that, on August 29, 2014, it raised an aggregate of $3,036,000 through the sale in a private placement transaction of 3,036 units (each a "Unit" and, collectively, the "Units"), at a price of $1,000 per Unit.  Each Unit consists of: (a) one share of Integrity's newly designated Series B 5.5% Convertible Preferred Stock (the "Series B Preferred Stock"), (b) a five year warrant to purchase, at an exercise price of $5.80 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock and (c) a five year warrant to purchase, at an exercise price of $10.00 per share, up to such number of shares of Integrity common stock equal to 100% of the shares of Integrity common stock issuable upon conversion of such share of Series B Preferred Stock.

The shares of Series B Preferred Stock and warrants offered in the private placement transaction and the shares of Integrity common stock issuable upon the conversion of the Series B Preferred Stock and/or the exercise of the warrants have not been registered under the Securities Act of 1933, as amended, or state securities laws, and may not be offered or sold in the United States unless such sale is made pursuant to an effective registration statement filed with the United States Securities and Exchange Commission (the "SEC") or pursuant to an applicable exemption from registration.  Integrity has agreed to file a registration statement with the SEC covering the shares of Integrity common stock issuable upon the conversion of the Series B Preferred Stock and/or the exercise of the warrants.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "expect," and "will," are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect Integrity Applications' actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release.  Factors that may affect Integrity Applications' results include, but are not limited to, the ability of Integrity Applications to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); the ability of Integrity Applications to successfully commercialize the GlucoTrack model DF-F; the ability of the GlucoTrack model DF-F to achieve acceptable pricing, adequate third party reimbursement or market acceptance; the ability of Integrity Applications to manage its growth and the expansion of its operations to include commercialization activities; risks relating to the use of third party manufacturers; risks relating to the development of Integrity Applications' sales, marketing and distribution capability, either on its own or through collaborations with marketing partners; and the additional risk factors described in Integrity Applications' filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2013.

Contact:

Eran Hertz, CFO
Integrity Applications
+972 (8) 675-7878 ext. #3
eranh@integrity-app.com

Logo - http://photos.prnewswire.com/prnh/20140702/124015


'/>"/>
SOURCE Integrity Applications, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Integrity Life Sciences Receives US FDA 510(k) Clearance for its Integrity Spinal Care System Medical Device
2. Kimberly-Clark Health Care Receives FDA Clearance For KIMGUARD ONE-STEP Sterilization Wrap Portfolio With One-Year Maintenance Of Package Integrity And Amsco V-PRO maX (Flexible Cycle)
3. Integrity Life Sciences Receives CE Mark and ISO Certifications for the Integrity Spinal Care System Medical Device
4. Integrity Life Sciences Announces Two US Patents
5. Integrity Life Sciences Expands Orthotic Options for Domestic and International Customers
6. Health Revenue Assurance Associates Hires Valerie Rinkle as Vice President of Revenue Integrity Informatics
7. Integrity Life Sciences Releases Corporate Resume
8. Verizon to Detail Health Care Fraud, Waste & Abuse - The Next Generation at National Association for Medicaid Program Integrity 2012 Conference, Sept. 18
9. Skin Integrity Products (SIP): Effective Distribution Networks Are Key to Penetrating Western European Market, Says Frost & Sullivan
10. Government Hospitals in Ecuador Continue to Invest in Integrity Life Sciences Technology
11. "Made with Integrity, In the USA, For the World!" is Now Trademarked
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 TFS is ... and Mr. Ed Tumaian , two global executive positions in ... be joining the Operational Leadership Team and will report to Dr. ... ... comes to TFS with 10 years of medical and scientific expertise ...
(Date:3/22/2017)... ROCKVILLE, Md. , March 22, 2017 ... that should be important to those following the industry.  This ... point-of-care (POC) RSV test, and the POC testing market ... grow. An Alere subsidiary is facing a legal battle ... Meanwhile, Beckman Coulter launched a new chemistry ...
(Date:3/22/2017)... CLARA, Calif. , March 22, 2017 /PRNewswire/ ... cardiology  solutions segment, Frost & Sullivan recognizes GE ... Company of the Year Award. GE Healthcare,s strategy ... end-to-end cardiac solutions has allowed it to effectively ... cardiac monitoring products space. In addition to aiding ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... 22, 2017 , ... Donor Network West, the federally-designated organ, ... announced the future opening of a CLIA certified dedicated laboratory in northern California ... determine the suitability of potential organ and tissue donors. This partnership will ...
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the ... HIV, reports Leslie Norins, MD, PhD. He says investigating this possibility, is ... Zika virus and in new infections with HIV. , His findings appear ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... imaging core lab with extensive therapeutic experience and operational excellence in oncology clinical ... immuno-oncology clinical trial for the treatment of non-small cell lung cancer and small ...
(Date:3/22/2017)... OK (PRWEB) , ... March 22, 2017 , ... ... insurance and financial planning services to regional families and business owners, is joining ... support to young people in the area. , A growing number of Oklahoma ...
(Date:3/22/2017)... ... March 22, 2017 , ... College basketball surges to its peak ... for recruiting – that is, recruiting people to be foster parents. Through a televised ... who are in foster care due to abuse, neglect and other family challenges. People ...
Breaking Medicine News(10 mins):